Investing in Healthcare
Mid market healthcare investments, with a core focus on Healthcare IT, Medical Devices, Home Health, Medical Groups and Medical Research
Our
Approach
FUTURE GROWTH
Seller retains up to 40% equity and realise additional value upon a second exit
LIGHT TOUCH
Manage your executive team independently
BUY-SIDE ADVISORY
Access resources and capital for accelerated growth
LEGACY
Enhance and preserve your legacy
EMPLOYEES
Continue taking care of your employees
FINANCIAL
Realize generational wealth
Enhancing Your Business
Huntingtsone Partners is building a unique group of independent technical, manufacturing, software and distribution healthcare companies with a goal of enhancing patient outcomes by driving organic growth and identifying operational synergies.
BUSINESS GROWTH
Portfolio companies are supported by industry-leading experts to achieve growth and operational improvements. As the business owner, we anticipate you will maintain a significant shareholding with the potential to realize additional substantial returns upon a second exit.
PROFIT ENHANCEMENT
Member companies enjoy the benefits of reduced operating costs, allowing for higher profitability. Additional key services such as marketing, legal, HR and accounting are centralized and offered at discounted rates.
STRATEGIC ACQUISITIONS
Huntingstone Partners’ M&A advisory resources and access to capital will assist you with strategic, rapid growth through bolt-on acquisitions. We will identify, vet, structure and finance acquisitions under your brand.
Meet The Team
Our Board of Directors, Board of Advisors, and executive leadership team consist of senior executives and medical professionals with in excess of 100 years of combined experience working in businesses at all stages of growth. Collectively we have closed on transactions of over $55 billion.
Kevin W. Massengill is the Executive Chairman of Meraglim Holdings Corporation, a professional, scientific, and technical investment holding company. He is the CEO of Raven Predictive Analytics Corp., the Managing Director of Massengill Advisory LLC, and the Non-Executive Board Chairman of fourteen investment holding companies.
Mr Massengill was an award-winning senior executive at Raytheon (NYSE: RTX) and Leidos (NYSE: LDOS), a managing director of a boutique investment bank, Silver Leaf Partners, in NYC, and the CEO of Consultancy Partners Group in Abu Dhabi.
A retired US Army Airborne Ranger qualified officer, he holds an M.A. from Princeton University and a B.A. from the University of Missouri-Columbia with continuing education at Harvard Law School's Program on Negotiation and INSEAD-Fontainebleau's International Directors Program.
A principled and proactive leader, Mr Miller brings nearly 40 years of legal corporate experience to the team. Initially as Partner and Of Counsel with Jones Day, then through a 30 year career at Procter & Gamble that culminated in six years as Vice Present General Counsel-Global Legal, he has led substantially sized legal teams of in-house and law firm lawyers in the US and across the globe, with a significant focus on Asia.
At P&G he led legal work to purchase Gillette and the extensive efforts to integrate the legal teams and entities, as well as joint venture negotiations with Sanofi-Aventis and major outsourcing arrangements with HP, IBM and Jones Lang Lasalle. At Jones Day, while representing clients in the consumer products, healthcare, retail, industrial materials and pharmaceutical sectors, his work included transactions, corporate governance, reorganizations and litigation.
He served as a Director of the Columbus Council on World Affairs, and teaches law and MBA students at Ohio State University Moritz College of Law and at University of Cincinnati Lindner College of Business.
Dr Anthony Russell, MD MBA MPH is a healthcare executive with over two decades in leadership and is leading as a Chief Administrative Officer with responsibility for all aspects of the day-to-day business operations, physician relationships, budgeting for a $75m revenue division, and managing 400+ employees and providers across 20 outpatient clinics.
Dr Russell has grown teams, enhanced quality, advanced patient-centered care, conducted turnarounds, directed strategic growth planning, executed successful acquisitions, and driven financial engineering to improve the organization’s bottom line.
Double boarded in Pediatrics and Clinical Informatics, Dr Russell is passionate about health and leveraging technology to advance care delivery. Dr Russell received his doctorate from the Medical University of South Carolina and then his masters degree from Johns Hopkins. He went on to complete his masters in business at the University of Massachusetts, Amherst.
Dr Russell is a business-savvy entrepreneur, turnaround expert, and investor with private equity holdings in many companies across multiple industries. Dr Russell has been a leader for some of the largest healthcare systems in the country as a healthcare executive and physician leader including UCSF, Sutter Health, Community Memorial, and Kaiser Permanente.
Brian is a seasoned professional with over 35 years of experience in various roles such as non-executive outside Board Director, Chief Audit Executive (CAE), Operating Partner, and Senior Advisor. He has served multinational and U.S. companies like KKR, Lazard, Morgan Stanley, D&T, and Grant Thornton, working in a range of ownership structures. Presently, Brian is an Operating Partner at Cadiz Capital and a Non-Executive Board member in several businesses in the fintech, healthcare, and investment industries.
Renowned for building effective relationships, supporting investors and Boards of Directors, and leading teams to outperform expectations, Brian leverages his passion for driving change and innovative approach to achieve transformative results. Prior to his current roles, Brian was the CAE at KKR, responsible for managing the Internal Audit, Enterprise Risk, and SOX functions, and served on various leadership committees.
Brian's education includes an MBA from Fordham University, where he now serves as an adjunct professor, and a BSc in Accounting and Finance from New York University. He holds several financial certifications. A resident of Summit, New Jersey, Brian is a sports enthusiast, travel lover, and health and fitness advocate.
A business and marketing strategist with over 20 years experience consulting to multinationals, SMEs, non-profits and charities, Mr Nicol's skillset spans communications & marketing strategy, media, brand, product commercialisation, M&A and business operations.
Working across healthcare & wellness, FMCG, premium home & lifestyle and arts & culture, he has delivered above industry growth through consumer facing brand and tactical campaigns, targeted lead generation, integrated conversion and retention strategies, and innovative creative thinking.
He has acquired and started-up multiple companies, non-profits and charities, in which he engineers growth and enhances profitability through operational improvements, marketing implementation and post-acquisition integration.
Mr Nicol drives value creation that enhances return on capital by leveraging marketing, operations and financial control off each other, and takes a strategic, analytic and wholistic approach to growth that allows multiple drivers to compound each other to realise greater value.
Contact us
Email: info@huntingstone.com
Tel (US): (610) 234-7785
Tel (AU): 0473 883 684
For any general inquiries, please fill in the following contact form:
BACK TO TOP